MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • MDS Virtual Congress 2020

    Defining time and anatomical specificity of basal ganglia white matter loss in premanifest Huntington’s disease

    P. Zeun, P. McColgan, T. Dhollander, S. Gregory, E. Johnson, M. Papoutsi, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)

    Objective: To identify when white matter connections first begin to degenerate in HD and which connections are most susceptible to early degeneration. Background: Huntington’s disease…
  • MDS Virtual Congress 2020

    Genetic analysis of Huntington’s Disease in a Brazilian Amazonian population

    D. Brito, M. Della Coletta, G. Ferreira, L. Amorim, S. Souza, S. Peixoto, C. Rezende (Manaus, Brazil)

    Objective: Characterize genetically a series of cases of patients with Huntington’s disease and their family members at risk in the city of Manaus, capital of…
  • MDS Virtual Congress 2020

    7 Tesla MRI investigation of cortical thickness in patients with Huntington’s disease and age-matched healthy controls

    M. Morrison, A. Jakary, S. Avadiappan, J. Tallakson, J. Glueck, A. Nelson, K. Possin, C. Dietiker, M. Geschwind, C. Hess, L. Lupo (San Francisco, CA, USA)

    Objective: Evaluate cortical thickness in Huntington's disease (HD) using 7 Tesla (T) MRI. Background: There are currently no effective disease-modifying therapies for HD. In order…
  • MDS Virtual Congress 2020

    Modelling Huntington’s disease diagnosed prevalence from diagnosed incidence and survival time

    V. Crowell, R. Houghton, F. Squitieri, A. Tomar, T. Fernandes (Basel, Switzerland)

    Objective: To develop an epidemiological model of manifest Huntington’s disease (HD) to estimate international HD diagnosed prevalence by Shoulson–Fahn Total Functional Capacity (TFC)-based Stage based…
  • MDS Virtual Congress 2020

    Apathy as a non-motor symptom(NMS) in patients with Parkinson’s disease(PwPD) and patients with Huntington’s disease(PwHD) in Tomsk, Russia

    M. Nikitina, V. Alifirova, K. Nurzhanova, N. Center, N. Zhukova (Tomsk, Russian Federation)

    Objective: The aim is to evaluate and compare the apathy profile in PwHD and PwPD, using the same clinical criteria to assess the severity of…
  • MDS Virtual Congress 2020

    Huntington’s disease in Egypt; A big challenge for a mysterious disease

    S. El-Jaafary, A. Sabbah, H. Amer (Cairo, Egypt)

    Objective: To identify the challenges of managing Huntington’s disease in Egypt in order to overcome them. Background: Huntington’s disease (HD) is considered a rare disease…
  • MDS Virtual Congress 2020

    Parkinsonism, delayed chorea and dystonia caused by extrapontine myelinolysis

    N.A Gandarilla Martínez, H.R Martínez Hernández (Mexico City, Mexico)

    Objective: To describe two case reports of patients with movement disorders due to extrapontine myelinolysis. Background: Central Pontine Myelinolysis (CPM) and Extra pontine myelinolysis (EPM)…
  • MDS Virtual Congress 2020

    Association between the number of CAG repetitions and cognitive performance in Huntington’s disease in patients of the National Institute of Neurology and Neurosurgery “MVS”

    D. Gasca-Saldaña, A. Vega-Rosas, G. Palma-Cordero, O. Castellanos-Maya (CDMX, Mexico)

    Objective: To establish the relationship between the number of CAG repetitions and the total Montreal Cognitive Assessment (MoCA) scores in patients with Huntington disease (HD).…
  • MDS Virtual Congress 2020

    Mcleod syndrome: Systematic review with meta-analysis

    A. Rochel Pérez, O. Cuevas Koh, K. Santos Zaldivar, R. Leal Ortega, R. Janssen-Aguilar, N. Mendez Dominguez (Mérida, Mexico)

    Objective: Analyze, review and describe the pathognomonic or characteristic signs and symptoms of Mcleod syndrome. Background: Mcleod syndrome is caused due to a mutation of…
  • 2019 International Congress

    Comorbidities and medications in Huntington’s disease, Parkinson’s disease and the general population in a US claims database

    L. Ishihara, E. Wild, D. Oliveri (Welwyn Garden City, United Kingdom)

    Objective: This study characterises the comorbidities and symptoms, and treatment patterns of patients with Huntington’s disease (HD) vs patients with Parkinson’s disease (PD) vs the…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley